APrf Rachel Black
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Rachel is a rheumatologist and clinician researcher who completed her PhD in 2019 looking at the epidemiology and patient perspectives of glucocorticoid use and adverse effects in rheumatoid arthritis and other inflammatory diseases. Her interests include pharmacoepidemiology and the use of big data to answer research questions directly relevant to her clinical practice in rheumatology.
Current Projects
A Randomised Clinical Trial of a Glucocorticoid Tapering Intervention for Rheumatoid Arthritis Patients- Recruitment complete.
Reassessing The Mortality Gap in Rheumatoid Arthritis in Australia- A data linkage project.
OMERACT Glucocorticoid Working Group- Systematic literature review looking at validated instruments for measuring glucocorticoid outcomes in clinical trials.
Epidemiology of Rheumatic Diseases in Australia- A collaborative data linkage project.
Optimising transition care for adolescents with juvenile rheumatic disease in South Australia- A collaborative multi-methods service improvement project.
| Date | Position | Institution name |
|---|---|---|
| 2018 - ongoing | Consultant Rheumatologist | The Queen Elizabeth Hospital |
| 2016 - ongoing | Clinical Lecturer | University of Adelaide |
| 2015 - ongoing | Consultant Rheumatologist | Royal Adelaide Hospital |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2015 | Scholarship | Arthritis SA/Australian Rheumatology Association (SA) Postgraduate Grant | - | - | - |
| 2014 | Scholarship | Australian Postgraduate Award (The University of Adelaide) | The University of Adelaide | Australia | - |
| 2013 | Fellowship | Ken Muirden Overseas Training Fellowship | Arthritis Research UK Centre for Epidemiology, The University of Manchester | United Kingdom | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2013 - 2019 | University of Adelaide | Australia | PhD |
| 1999 - 2004 | University of Adelaide | Australia | MBBS |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2007 - 2012 | FRACP | Royal Australasian College of Physicians | Australia |
| Year | Citation |
|---|---|
| 2025 | Russell, O., Lester, S., Black, R. J., Lassere, M., Barrett, C., March, L., . . . Hill, C. L. (2025). Area-level socioeconomic status impacts healthcare visit frequency by Australian inflammatory arthritis patients: results from the Australian Rheumatology Association Database. Arthritis Care and Research, 77(1), 127-135. |
| 2025 | Tieu, J., Cheah, J. T., Lyne, S., Yip, K., Ghosh, N., Richards, P., . . . Goodman, S. M. (2025). Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in Arthritis and Rheumatism, 71, 6 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Bryant, M. J., Black, R. J., & Hill, C. L. (2025). Measuring Patient Experience in Rheumatology Outpatient Care. International Journal of Rheumatic Diseases, 28(1), 3 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Lyon, A., Lester, S., Stanhope, J., Lynch, T., Black, R., Barrett, C., . . . Hill, C. (2025). Dual-energy x-ray absorptiometry (DEXA) and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis (RA) using data from the Australian Rheumatology Association Database (ARAD). Internal Medicine Journal, 55(7), 1127-1135. |
| 2025 | Bryant, M. J., Lester, S., Russell, O., Whittle, S., Limaye, V., Proudman, S., . . . Hill, C. L. (2025). Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients. Rheumatology International, 45(6), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Lynch, T., Barrett, C., Black, R., Buchbinder, R., Carroll, G., Chand, V., . . . March, L. (2025). Agreement Between Self-Reported Antirheumatic Medications and Pharmaceutical Claims in an Australian Inflammatory Arthritis Cohort. ACR Open Rheumatology, 7(10), e70105-1-e70105-13. |
| 2025 | Witts, M., Buchbinder, R., Lester, S., Stanhope, J., Chand, V., Barrett, C., . . . Robinson, P. C. (2025). Patient experiences and perspectives of DMARD monitoring in Australians with long-disease-duration rheumatoid arthritis and psoriatic arthritis.. BMC Rheumatol, 9(1), 126. |
| 2024 | Lyne, S. A., Yip, K., Vasiliou, V. S., Katz, D. A., Richards, P., Tieu, J., . . . Hill, C. L. (2024). Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases. Seminars in Arthritis and Rheumatism, 64, 7 pages. Scopus1 WoS1 |
| 2024 | Pisaniello, H. L., Lester, S. E., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. L. (2024). The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases, 83(10), 1400-1402. |
| 2024 | Bryant, M. J., Black, R. J., Lester, S., Chand, V., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2024). Australian adaptation and external validation of Commissioning for Quality in Rheumatoid Arthritis-RA-Patient Reported Experience Measure (CQRA-RA-PREM). Rheumatology Advances in Practice, 8(4), 9 pages. Scopus2 WoS2 Europe PMC3 |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. L. (2023). Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open, 9(3), e002962. Scopus7 WoS7 Europe PMC4 |
| 2023 | Black, R. J., Cross, M., Haile, L. M., Culbreth, G., Steinmetz, J., Hagins, H., . . . March., L. M. (2023). Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. LANCET RHEUMATOLOGY, 5(10), E594-E610. Scopus393 WoS300 |
| 2023 | Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. C. (2023). Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure.. Rheumatology (Oxford), 62(11), 3565-3575. Scopus5 WoS5 Europe PMC4 |
| 2023 | Black, R. J., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2023). Mortality estimates and excess mortality in rheumatoid arthritis. Rheumatology, 62(11), 3576-3583. Scopus37 WoS39 Europe PMC31 |
| 2023 | Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9. Scopus7 WoS5 Europe PMC5 |
| 2023 | Russell, O., Lester, S., Black, R. J., & Hill, C. L. (2023). Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review. Arthritis Care and Research, 75(1), 92-100. Scopus15 WoS14 Europe PMC10 |
| 2022 | McMaster, C., Liew, D. F. L., Lester, S., Rischin, A., Black, R. J., Chand, V., . . . Hill, C. L. (2022). COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology, 62(4), 1-7. Scopus3 WoS4 Europe PMC2 |
| 2022 | Ruediger, C., Ninan, J., Dyer, K., Lyne, S., Tieu, J., Black, R. J., . . . Hill, C. L. (2022). Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length. Frontiers in Medicine, 9, 6 pages. Scopus5 WoS3 Europe PMC3 |
| 2022 | Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7. Scopus6 WoS6 Europe PMC6 |
| 2021 | Tieu, J., Cheah, J. T., Black, R. J., Christensen, R., Ghosh, N., Richards, P., . . . Hill, C. L. (2021). Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. Seminars in Arthritis and Rheumatism, 51(5), 1139-1145. Scopus13 WoS9 Europe PMC8 |
| 2021 | Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Hill, C. (2021). Healthcare access and attitudes towards telehealth during the early phase of the COVID ‐19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal, 51(5), 788-792. Scopus4 WoS4 Europe PMC4 |
| 2021 | Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238. Scopus13 WoS15 Europe PMC11 |
| 2021 | Bryant, M. J., Schubert, J. P., Black, R. J., & Hill, C. L. (2021). Patient-Reported Experience Measures in outpatient rheumatology care: A systematic review. Rheumatology Advances in Practice, 5(3), 10 pages. Scopus6 WoS2 Europe PMC5 |
| 2020 | Cheah, J. T., Robson, J. C., Black, R. J., Goodman, S. M., Lester, S., Mackie, S. L., & Hill, C. L. (2020). The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group. Seminars in Arthritis and Rheumatism, 50(5), 996-1005. Scopus28 WoS32 Europe PMC25 |
| 2020 | Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2020). Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care.. Internal medicine journal, 50(9), 1067-1072. Scopus8 WoS6 Europe PMC6 |
| 2019 | Cheah, J. T. L., Black, R. J., Robson, J. C., Navarro-Millán, I. Y., Young, S. R., Richards, P., . . . Hill, C. L. (2019). Toward a core domain set for glucocorticoid impact in inflammatory rheumatic diseases: The OMERACT 2018 glucocorticoid impact working group. Journal of Rheumatology, 46(9), 1179-1182. Scopus10 WoS10 Europe PMC6 |
| 2019 | Black, R. J., Richards, B., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., . . . Hill, C. L. (2019). Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 49(3), 351-357. Scopus14 WoS11 Europe PMC10 |
| 2019 | Hoon, E., Ruediger, C., Gill, T., Black, R., & Hill, C. (2019). A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis. Open Access Rheumatology : Research and Reviews, 11, 189-198. Scopus11 WoS11 Europe PMC8 |
| 2019 | Flurey, C. A., Tugwell, P. S., Black, R. J., Halls, S., Page, M. J., Robson, J. C., . . . Richards, B. (2019). The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future. JOURNAL OF RHEUMATOLOGY, 46(8), 1047-1052. Scopus6 WoS6 Europe PMC3 |
| 2017 | Black, R. J., Robson, J. C., Goodman, S. M., Hoon, E., Lai, L. Y. H., Simon, L. S., . . . Hill, C. L. (2017). A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: report from the OMERACT 2016 special interest group. Journal of Rheumatology, 44(11), 1754-1758. Scopus22 WoS21 Europe PMC16 |
| 2017 | Mackie, S. L., Twohig, H., Neill, L. M., Harrison, E., Shea, B., Black, R. J., . . . Hill, C. L. (2017). The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica. Journal of Rheumatology, 44(10), 1515-1521. Scopus40 WoS34 Europe PMC32 |
| 2017 | Black, R. J., Goodman, S. M., Ruediger, C., Lester, S., Mackie, S. L., & Hill, C. L. (2017). A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: The patient perspective. Journal of Clinical Rheumatology, 23(8), 416-420. Scopus25 WoS25 Europe PMC16 |
| 2017 | Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8. Scopus38 WoS38 Europe PMC30 |
| 2016 | Lester, S., Hewitt, A., Ruediger, C., Bradbury, L., De Smit, E., Wiese, M., . . . Hill, C. (2016). PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open, 2(1), e000246-1-e000246-3. Scopus8 WoS10 Europe PMC5 |
| 2016 | Hill, C. L., Black, R. J., Nossent, J. C., Ruediger, C., Nguyen, L., Ninan, J. V., & Lester, S. (2016). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 46(4), 513-519. Scopus67 WoS65 Europe PMC50 |
| 2016 | Black, R. J., Hill, C. L., Lester, S., & Dixon, W. G. (2016). The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: a systematic review and meta- analysis. PLoS ONE, 11(11), e0166468. Scopus43 WoS38 Europe PMC32 |
| 2015 | Black, R., Joseph, R., Brown, B., Movahedi, M., Lunt, M., & Dixon, W. (2015). Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: A retrospective drug utilisation study. Arthritis Research and Therapy, 17(1), 375. Scopus28 WoS25 Europe PMC24 |
| 2014 | Black, R. J., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. M. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522. Scopus14 WoS14 Europe PMC10 |
| 2014 | Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39. Scopus62 WoS56 Europe PMC48 |
| 2013 | Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357. Scopus17 WoS15 Europe PMC15 |
| 2013 | Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4. WoS1 Europe PMC1 |
| 2012 | Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4. Scopus5 WoS7 Europe PMC5 |
| 2011 | Black, R., Limaye, V., & Cleland, L. (2011). Acute Monoarthritis: What should one do?. Medicine Today: the peer reviewed journal of clinical practice, 12(3), 49-55. |
| Year | Citation |
|---|---|
| 2023 | Ninan, J., Ruediger, C., Dyer, K. A., Dodd, T., Black, R. J., Lyne, S., . . . Hill, C. L. (2023). Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014–2020. In Frontiers in Medicine Vol. 10 (pp. 5 pages). Switzerland: FRONTIERS MEDIA SA. DOI Scopus2 WoS2 Europe PMC1 |
| 2023 | Bryant, M. J., Munt, R., Black, R. J., Reynolds, A., & Hill, C. L. (2023). Joining forces to understand what matters most: qualitative insights into the patient experience of outpatient rheumatology care. In Rheumatology Advances in Practice Vol. 7 (pp. 10 pages). England: OXFORD UNIV PRESS. DOI Scopus6 WoS5 Europe PMC4 |
| 2022 | Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. |
| 2022 | Russell, O., Lester, S., Black, R., Lassere, M., Barrett, C., March, L., . . . Hill, C. (2022). EFFECT OF SOCIOECONOMIC STATUS (SES) ON OPIOID AND GLUCOCORTICOID USE IN AUSTRALIAN RHEUMATOID ARTHRITIS (RA) PATIENTS: A MEDICINE DISPENSING ANALYSIS USING DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39-40). WILEY. WoS1 |
| 2022 | Lynch, T., Sinnathurai, P., Buchbinder, R., Hill, C., Russell, O., Lester, S., . . . March, L. (2022). PREDICTORS OF DISCORDANT PRESCRIPTION MEDICATION SELF-REPORT IN THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD) COHORT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39). WILEY. |
| 2022 | Russell, O., Lester, S., Black, R., Lassere, M., Barrett, C., March, L., . . . Hill, C. (2022). THE EFFECT OF AREA-LEVEL SOCIOECONOMIC STATUS (SES) ON FUNCTIONAL STATUS IN AUSTRALIAN RHEUMATOID ARTHRITIS (RA) PATIENTS: DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 11). WILEY. |
| 2021 | Russell, O., Lester, S., Black, R., & Hill, C. (2021). SOCIOECONOMIC STATUS (SES) AND MEDICATION USE IN RHEUMATOID ARTHRITIS (RA): A SCOPING REVIEW. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 1098-1099). ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI |
| 2021 | Bridgewater, S., Dawson, J., Ndosi, M., Black, R. J., Cheah, T. L., Dures, E., . . . Robson, J. (2021). DEVELOPMENT OF A CONCEPTUAL FRAMEWORK FOR A PATIENT REPORTED OUTCOME MEASURE TO CAPTURE PATIENTS' PERCEPTIONS OF GLUCOCORTICOID THERAPY DURING TREATMENT FOR RHEUMATIC DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 1441). Virtual Congress: BMJ PUBLISHING GROUP. DOI WoS4 |
| 2021 | He, J., Sunny, L., Sallis, O., McWilliams, L., Spargo, L., Metcalf, R., . . . Proudman, S. (2021). PULMONARY FUNCTION ABNORMALITIES IN RHEUMATOID ARTHRITIS, TO SCREEN OR NOT TO SCREEN?. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 39). WILEY. |
| 2021 | Black, R., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2021). MORTALITY ASSOCIATED WITH RHEUMATOID ARTHRITIS IN AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE PARTICIPANTS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37-38). WILEY. |
| 2021 | Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Marine, F., . . . Hill, C. (2021). VACCINATION RATES, PERCEPTIONS AND INFORMATION SOURCES UTILISED BY AUSTRALIAN PATIENTS WITH INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 15). WILEY. |
| 2020 | Russell, O., Lester, M. S., Black, R., & Hill, C. (2020). SOCIOECONOMIC STATUS (SES) AND MEDICATION USE IN RHEUMATOID ARTHRITIS (RA): A SCOPING REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 23). WILEY. |
| 2020 | Black, R., Lester, S., Hill, C., & Dixon, W. (2020). ORAL GLUCOCORTICOID USE AND THE DEVELOPMENT OF CATARACTS AND GLAUCOMA IN PATIENTS WITH INCIDENT RHEUMATOID ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 46-47). WILEY. |
| 2018 | Fletcher, A., Lassere, M., Black, R., Barrett, C., Carroll, G., Lester, S., . . . Hill, C. (2018). Socioeconomic Differences in Opioid Use By People with Inflammatory Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 1 page). IL, Chicago: WILEY. |
| 2015 | Black, R. J., Joseph, R. M., Movahedi, M., Lunt, M., & Dixon, W. G. (2015). PRESCRIBER INFLUENCE ON ORAL GLUCOCORTICOID PRESCRIBING IN UK PRIMARY CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 1291). BMJ PUBLISHING GROUP. DOI |
| 2015 | Black, R. J., Joseph, R. M., Movahedi, M., Lunt, M., & Dixon, W. G. (2015). Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. |
| Year | Citation |
|---|---|
| 2022 | Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. (2022). PATIENT PERCEPTIONS OF IMPACT OF GLUCOCORTICOID THERAPY IN THE RHEUMATIC DISEASES: INTERNATIONAL DEVELOPMENT OF A TREATMENT-SPECIFIC PATIENT REPORTED OUTCOME MEASURE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. DENMARK, Copenhagen: BMJ PUBLISHING GROUP. DOI |
| 2021 | Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Hill, C. (2021). HEALTHCARE ACCESS AND ATTITUDES TOWARDS TELEHEALTH DURING THE EARLY PHASE OF THE COVID-19 PANDEMIC AMONG AN AUSTRALIAN COHORT WITH INFLAMMATORY ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2021 | Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2021). ATTITUDES OF AUSTRALIANS WITH INFLAMMATORY ARTHRITIS TO BIOLOGIC THERAPY AND BIOSIMILARS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2020). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Black, R., Lester, S., Ninan, J., Ruediger, C., & Hill, C. (2020). INCIDENCE AND PREVALENCE OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA RECORDED IN AUSTRALIAN PRIMARY CARE ELECTRONIC MEDICAL RECORDS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2019 | Black, R., Lester, S., Hill, C., & Dixon, W. (2019). THE IMPACT OF ORAL GLUCOCORTICOIDS ON THE DEVELOPMENT OF CATARACTS AND GLAUCOMA IN INCIDENT RHEUMATOID ARTHRITIS PATIENTS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP. DOI |
| 2018 | Cheah, J., Robson, J., Black, R., Goodman, S. M., Lester, S., Mackie, S., & Hill, C. (2018). The Patient's Perspective of Glucocorticoid Use: A Systematic Literature Review of Quantitative and Qualitative Studies. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. IL, Chicago: WILEY. |
| 2016 | Black, R., Goodman, S. M., Ruediger, C., Lester, S., Mackie, S., & Hill, C. (2016). Glucocorticoid Adverse Effects - the Patient Perspective. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. |
| 2015 | Hill, C., Black, R., Nossent, J., Ruediger, C., Ninan, J., & Lester, S. (2015). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Poster session presented at the meeting of Abstracts of the 2015 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Francisco, CA: Wiley-Blackwell. DOI WoS2 |
Primary Investigator Grants
1. Arthritis Australia- Australian Rheumatology Association Project Grant
Title: A Randomised Clinical Trial of a Glucocorticoid Tapering Intervention for Rheumatoid Arthritis Patients
Amount: $43,000
Period of award: 2023
Co-Investigator Grants
1. The Hospital Research Foundation Group- Advancing Diagnosis or Treatment of Child and Adolescent Rheumatic Diseases grant round
Title: Optimising transition care for adolescents with juvenile rheumatic disease in South Australia
Amount: $125,000
Period of Award: 2023-2025
PI: Prof Catherine Hill
2. Arthritis Australia 2021-2022 National Research Program- Australian Rheumatology Association Grant-In-Aid
Title: Validation and integration of Patient Reported Experience Measures in outpatient rheumatology care in Australia
Amount: $15,000
Period of Award: 2022
PI: Dr Madeline Bryant
3. Arthritis Australia National Research Program 2020- Australian Rheumatology Association Project Grant
Title: Development of a patient reported outcome measure (prom) for glucocorticoid impact in rheumatic diseases
Amount: $15,000
Period of Award: 2021
PI: Prof Catherine Hill
Other Funding
ARA Early Career Excellence Award 2024 Amount: $2,000
RACP Barbara Cameron ARA Research Establishment Fellowship 2020 Amount: $50,000
Arthritis SA/ARA SA Branch Postgraduate Scholarship 2015 Amount: $20,000
Australian Postgraduate Award, The University of Adelaide (for PhD) 2014 Amount: $25,392 per year
Arthritis Australia Ken Muirden Overseas Training Fellowship 2013 Amount: $100,000
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 | Co-Supervisor | The influence of socioeconomic factors on medication use and health outcomes in Australians with rheumatoid arthritis | Doctor of Philosophy | Doctorate | Part Time | Dr Oscar Kenneth Russell |
| 2023 | Co-Supervisor | The influence of socioeconomic factors on medication use and health outcomes in Australians with rheumatoid arthritis | Doctor of Philosophy | Doctorate | Full Time | Dr Oscar Kenneth Russell |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 - 2025 | Co-Supervisor | Patient experience in Australian outpatient rheumatology care | Doctor of Philosophy | Doctorate | Full Time | Dr Madeleine Bryant |
